Advanced Bionics' cochlear implant system gets FDA approval:
This article was originally published in Clinica
Advanced Bionics has received US FDA approval for its Clarion HiFocus Electrode for use in people who become deaf as adults. The device is the first approved technology that selectively stimulates targeted groups of hearing nerve fibres. Externally worn components process sound into digital code, which is transmitted via radio waves to the surgically implanted electronics. These deliver impulses via the electrode array which is inserted into the inner ear and delivers electrical current to hearing nerve fibers, said the Sylmar, California-based company.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.